Treating Huh7 and H1299 cells with mTOR inhibitors rapamycin and Torin1 blocked mTOR signaling (evidenced by decreased S6K phosphorylation) but did not reduce total AMPK levels (Extended Data Fig
Targeting the apoptosis pathway may prove to be a promising approach to overcoming drug resistance in CSCs
Tirzepatide doesn't affect the metabolism of contraceptive hormones
FDA-approved GLP-1 receptor agonists include semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Hard to see how Part D plans cover these drugs and indications without substantial additional spending
The peptide is now tethered to albumin and inherits albumin's natural 19 to 21 day plasma residence [3]